41 results
8-K
CRNX
Crinetics Pharmaceuticals Inc
3 Jun 24
Regulation FD Disclosure
4:35pm
website. The Company intends to deliver the corporate presentation during a conference call and live webcast with the investment community on June 3
8-K
CRNX
Crinetics Pharmaceuticals Inc
19 Mar 24
Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
6:31am
website. The Company intends to deliver the corporate presentation during a conference call and live webcast with the investment community on March 19
8-K
EX-99.2
CRNX
Crinetics Pharmaceuticals Inc
12 Mar 24
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
4:25pm
, including academic and community medical oncologist and other HCP opinions collected during market research. This data involves a number … frequently. Or if they said, ‘I can’t take this injection’ or ‘I don’t want to get injections,’ we can consider [Paltusotine].” - Med Onc, Community
8-K
CRNX
Crinetics Pharmaceuticals Inc
12 Mar 24
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
4:25pm
intends to deliver the corporate presentation during a conference call and live webcast with the investment community on March 12, 2024, at 4:30 p.m
8-K
5c8wzi
18 Dec 23
Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome
4:12pm
8-K
g7s9d69ej1j69
11 Sep 23
Regulation FD Disclosure
6:05am
8-K
EX-99.2
enemn31o069k6ffrfn
11 Sep 23
Regulation FD Disclosure
6:05am
8-K
66xfh6gbnjap5
25 May 22
Regulation FD Disclosure
7:02am
8-K
jti8j4niyoxst2h9x
30 Mar 22
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
j9cz63 f2t4
15 Sep 21
Regulation FD Disclosure
4:05pm
8-K
oya nwl8a
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm